Colgate-Palmolive Company (CL)

Currency in USD
83.49
-0.67(-0.80%)
Closed·
83.20-0.29(-0.35%)
·
Earnings results expected in 15 days
CL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
82.6084.36
52 wk Range
74.5599.33
Key Statistics
Prev. Close
84.16
Open
84
Day's Range
82.6-84.36
52 wk Range
74.55-99.33
Volume
4.45M
Average Vol. (3m)
6.74M
1-Year Change
-10.6963%
Book Value / Share
0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
95.53
Upside
+14.42%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill’s Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill’s Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Colgate-Palmolive Company SWOT Analysis


Currency Dynamics
Learn how Colgate-Palmolive's global market position could lead to significant outperformance if the USD weakens, boosting international operations
Financial Outlook
Analysts project EPS of $3.67 for the current fiscal year, rising to $3.87 next year, with price targets ranging from $87 to $97
Strategic Evolution
Explore Colgate-Palmolive's transition from its successful 2025 strategy to an ambitious 2030 plan, focusing on unlocking new growth potential
Global Resilience
Colgate-Palmolive demonstrates market resilience with a $63.01B market cap and 60.62% gross profit margin, navigating global challenges effectively
Read full SWOT analysis

Colgate-Palmolive Company Earnings Call Summary for Q4/2025

  • Colgate-Palmolive exceeded Q4 2025 forecasts with EPS of $0.95 vs $0.91 and revenue of $5.23B vs $5.12B, driving a 3.65% pre-market stock increase to $88.35.
  • The company reported record operating cash flow of $4.2B and 4.5% organic growth in emerging markets, despite volatile conditions in North America.
  • CEO Noel Wallace highlighted growth across organic sales, net sales, gross profit, base business EPS, and free cash flow for fiscal year 2025.
  • For 2026, Colgate-Palmolive projects organic sales growth of 1-4%, with North American challenges expected to improve in the second half of the year.
  • Strategic initiatives including the Strategic Growth and Productivity Program and investments in digital and AI capabilities are positioned to support future growth.
Last Updated: 01/30/2026, 09:37 AM
Read Full Transcript
Colgate-Palmolive investor slides for Q4/2025
Colgate-Palmolive Q4 2025 slides
Last Update: Jan 30, 2026
See full investor slides

Compare CL to Peers and Sector

Metrics to compare
CL
Peers
Sector
Relationship
P/E Ratio
31.4x23.0x12.0x
PEG Ratio
−1.26−1.390.03
Price / Book
1,240.4x5.5x1.5x
Price / LTM Sales
3.3x2.3x0.9x
Upside (Analyst Target)
16.4%31.8%21.8%
Fair Value Upside
Unlock10.3%11.6%Unlock

Analyst Ratings

12 Buy
7 Hold
0 Sell
Ratings:
19 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 95.53
(+14.42% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Hold79.00-5.38%88.00MaintainApr 15, 2026
BofA Securities
Buy102.00+22.17%105.00MaintainApr 10, 2026
RBC Capital
Buy102.00+22.17%104.00MaintainApr 09, 2026
Piper Sandler
Buy92.00+10.19%96.00MaintainApr 08, 2026
Wells Fargo
Hold92.00+10.19%100.00MaintainApr 08, 2026

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.63%
Dividend Yield
2.52%
Industry Median 2.81%
Annualized Payout
2.12
Paid quarterly
5-Years Growth
+3.32%
Growth Streak

Earnings

Latest Release
Jan 30, 2026
EPS / Forecast
0.95 / 0.91
Revenue / Forecast
5.23B / 5.12B
EPS Revisions
Last 90 days

CL Income Statement

People Also Watch

430.58
SPGI
+1.26%
75.31
KO
-0.78%
143.38
PG
-0.69%
87.10
MDT
-1.16%
411.27
MSFT
+4.62%

FAQ

What Is the Colgate-Palmolive (CL) Stock Price Today?

The Colgate-Palmolive stock price today is 83.49 USD.

What Stock Exchange Does Colgate-Palmolive Trade On?

Colgate-Palmolive is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Colgate-Palmolive?

The stock symbol for Colgate-Palmolive is "CL."

Does Colgate-Palmolive Pay Dividends? What’s The Current Dividend Yield?

The Colgate-Palmolive dividend yield is 2.54%.

What Is the Colgate-Palmolive Market Cap?

As of today, Colgate-Palmolive market cap is 67.06B USD.

What Is Colgate-Palmolive's Earnings Per Share (TTM)?

The Colgate-Palmolive EPS (TTM) is 2.63.

When Is the Next Colgate-Palmolive Earnings Date?

Colgate-Palmolive will release its next earnings report on May 01, 2026.

From a Technical Analysis Perspective, Is CL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Colgate-Palmolive Stock Split?

Colgate-Palmolive has split 5 times.

How Many Employees Does Colgate-Palmolive Have?

Colgate-Palmolive has 33600 employees.

What is the current trading status of Colgate-Palmolive (CL)?

As of Apr 16, 2026, Colgate-Palmolive (CL) is trading at a price of 83.49 USD, with a previous close of 84.16 USD. The stock has fluctuated within a day range of 82.60 USD to 84.36 USD, while its 52-week range spans from 74.55 USD to 99.33 USD.

What Is Colgate-Palmolive (CL) Price Target According to Analysts?

The average 12-month price target for Colgate-Palmolive is 95.53 USD, with a high estimate of 105 USD and a low estimate of 79 USD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +14.42% Upside potential.

What Is the CL Premarket Price?

CL's last pre-market stock price is 83.90 USD. The pre-market share volume is 1,690.00, and the stock has decreased by -0.26, or -0.31%.

What Is the CL After Hours Price?

CL's last after hours stock price is 83.20 USD, the stock has decreased by -0.29, or -0.35%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.